Connection

Martin Bachmann to Vaccination

Back to Details
This is a "connection" page, showing publications Martin Bachmann has written about Vaccination.
Martin Bachmann
Connection Strength
0.690
Vaccination
  1. Strategies to Prevent SARS-CoV-2-Mediated Eosinophilic Disease in Association with COVID-19 Vaccination and Infection. Int Arch Allergy Immunol. 2020; 181(8):624-628.
    View in: PubMed
    Score: 0.138
  2. Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine. Front Immunol. 2019; 10:1015.
    View in: PubMed
    Score: 0.128
  3. Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects. J Allergy Clin Immunol. 2019 07; 144(1):193-203.
    View in: PubMed
    Score: 0.128
  4. Vaccination against IL-31 for the treatment of atopic dermatitis in dogs. J Allergy Clin Immunol. 2018 07; 142(1):279-281.e1.
    View in: PubMed
    Score: 0.118
  5. Treating insect-bite hypersensitivity in horses with active vaccination against IL-5. J Allergy Clin Immunol. 2018 10; 142(4):1194-1205.e3.
    View in: PubMed
    Score: 0.118
  6. Early Transcriptional Signature in Dendritic Cells and the Induction of Protective T Cell Responses Upon Immunization With VLPs Containing TLR Ligands-A Role for CCL2. Front Immunol. 2019; 10:1679.
    View in: PubMed
    Score: 0.032
  7. Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination. J Control Release. 2017 04 10; 251:92-100.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.